The effect of Resveratrol on the expression of the granulosa apoptosis-associated genes in polycystic ovary syndrome and its relationship with in vitro fertilization outcome

Phase 3

• Conditions: polycystic ovarian syndrome: PCOS.; polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20200905048630N1
• Lead Sponsor: Bandare-abbas University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Women with polycystic ovary syndrome based on Rotterdam criteria
Women of childbearing age between 18 and 40 years
Candidate for in vitro fertilization
Not receiving insulin

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Apoptosis. Timepoint: 40 days after the beginning of the intervention. Method of measurement: real time pcr.

Secondary Outcome Measures

Name	Time	Method
Egg numbers. Timepoint: 40 days after the beginning of the intervention. Method of measurement: Counting.;Number of embryos. Timepoint: 43 days after the beginning of the intervention. Method of measurement: Counting.;Number of good quality embryo. Timepoint: 43 days after the beginning of the intervention. Method of measurement: Counting.